Literature DB >> 20515457

Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2.

Irini P Chatziralli1, Theodoros N Sergentanis, Petros Keryttopoulos, Nikolaos Vatkalis, Antonis Agorastos, Leonidas Papazisis.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is associated with microvascular complications, such as diabetic retinopathy (DR). DR is one of the main causes of visual loss in individuals aged 20-64 years old. This study aims to investigate the independent associations between the stage of DR and a variety of possible risk factors, including years since DM diagnosis, HbA1c levels, the coexistence of hypertension, age and gender.
FINDINGS: 120 patients were recruited in the Department of Internal Medicine, Veroia General Hospital, Veroia, Greece, and the DR stage was defined by an ophthalmologist. Afterwards, the DR association with the aforementioned factors was examined. Univariate and multivariate analysis (multivariate ordinal logistic regression) was performed. At the univariate analysis, there was a positive association between DR severity and age (Spearman's rho = 0.4869, p < 0.0001), years since DM diagnosis (Spearman's rho = 0.6877, p < 0.0001), HbA1c levels (Spearman's rho = 0.6315, p < 0.0001), history of hypertension (2.47 +/- 1.37 vs. 0.50 +/- 0.80 for patients without hypertension; p < 0.0001) and male sex (2.56 +/- 1.41 vs. 2.05 +/- 1.45 for female patients; p = 0.045, MWW). All these factors, except for age, retained their statistical significance at the multivariate ordinal logistic model.
CONCLUSIONS: Years since DM diagnosis, hypertension, HbA1c levels and male sex are independently associated with severe DR. The effect of age seems to reflect a confounding association.

Entities:  

Year:  2010        PMID: 20515457      PMCID: PMC2888829          DOI: 10.1186/1756-0500-3-153

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


  10 in total

1.  Blindness caused by diabetes--Massachusetts, 1987-1994.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1996-11-01       Impact factor: 17.586

Review 2.  Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.

Authors:  C P Wilkinson; Frederick L Ferris; Ronald E Klein; Paul P Lee; Carl David Agardh; Matthew Davis; Diana Dills; Anselm Kampik; R Pararajasegaram; Juan T Verdaguer
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

3.  Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4.

Authors:  R Pradeepa; B Anitha; V Mohan; A Ganesan; M Rema
Journal:  Diabet Med       Date:  2008-03-13       Impact factor: 4.359

4.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

5.  Major eye diseases and risk factors associated with systemic hypertension in an adult Chinese population: the Beijing Eye Study.

Authors:  Shuang Wang; Liang Xu; Jost B Jonas; Tien Y Wong; Tongtong Cui; Yibin Li; Ya Xing Wang; Qi Sheng You; Hua Yang; Cong Sun
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

6.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

7.  Risk factors for diabetic retinopathy in self-reported rural population with diabetes.

Authors:  P K Rani; R Raman; A Chandrakantan; S S Pal; G M Perumal; T Sharma
Journal:  J Postgrad Med       Date:  2009 Apr-Jun       Impact factor: 1.476

Review 8.  Metabolic control and diabetic retinopathy.

Authors:  Monica Rodriguez-Fontal; John B Kerrison; D Virgil Alfaro; Eric P Jablon
Journal:  Curr Diabetes Rev       Date:  2009-02

9.  Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study.

Authors:  Mahfouth A Bamashmus; Abdallah A Gunaid; Rajiv B Khandekar
Journal:  Indian J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 1.848

10.  Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation.

Authors:  Jorge Esteves; Carolina Maurente da Rosa; Caroline Kaercher Kramer; Luiz Eduardo Osowski; Stéfano Milano; Luís Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2009-10-05       Impact factor: 3.320

  10 in total
  28 in total

1.  Quantification of Retinal Nonperfusion and Neovascularization With Ultrawidefield Fluorescein Angiography in Patients With Diabetes and Associated Characteristics of Advanced Disease.

Authors:  Gina Yu; Michael T Aaberg; Tapan P Patel; Rahul S Iyengar; Corey Powell; Annie Tran; Caitlin Miranda; Emma Young; Katarina Demetriou; Laxmi Devisetty; Yannis M Paulus
Journal:  JAMA Ophthalmol       Date:  2020-06-01       Impact factor: 7.389

2.  Risk factors for diabetic retinopathy in northern Chinese patients with type 2 diabetes mellitus.

Authors:  Zhi-Peng Yan; Jing-Xue Ma
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

Review 3.  Current approaches to the management of diabetic retinopathy and diabetic macular oedema.

Authors:  Francesco Boscia
Journal:  Drugs       Date:  2010-11-12       Impact factor: 9.546

4.  Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus.

Authors:  Ze-Long Zhong; Mei Han; Song Chen
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

5.  Estrogen prevents high-glucose-induced damage of retinal ganglion cells via mitochondrial pathway.

Authors:  Ming Hao; Yue Li; Wenjian Lin; Qian Xu; Ning Shao; Yixin Zhang; Hongyu Kuang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-09-13       Impact factor: 3.117

6.  Knowledge of Primary Prevention of Diabetic Retinopathy among General Ophthalmologists, Mid Level Eye Care Personnel and General Physicians in Oman.

Authors:  Rajiv Khandekar; Rajesh Deshmukh; Urmi Vora; Saleh Al Harby
Journal:  Middle East Afr J Ophthalmol       Date:  2011-07

Review 7.  Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean region.

Authors:  Rajiv Khandekar
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Apr-Jun

8.  Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study.

Authors:  Roqayeh Aliyari; Ebrahim Hajizadeh; Ashraf Aminorroaya; Farshad Sharifi; Iraj Kazemi; Ahmad-Reza Baghestani
Journal:  Diabetes Metab Syndr Obes       Date:  2020-05-28       Impact factor: 3.168

9.  Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population.

Authors:  Ze-long Zhong; Song Chen
Journal:  Exp Diabetes Res       Date:  2012-10-14

10.  Association of Pro12Ala polymorphism in peroxisome proliferator activated receptor gamma with proliferative diabetic retinopathy.

Authors:  Khadija Tariq; Saira Bano Malik; Syeda Hafiza Benish Ali; Sundas Ejaz Maqsood; Aisha Azam; Irfan Muslim; Muhammad Shakil Khan; Maleeha Azam; Nadia Khalida Waheed; Raheel Qamar
Journal:  Mol Vis       Date:  2013-03-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.